-- Clinical data was gathered from eleven patients with gastrointestinal (GI) aGvHD treated with MaaT013,…
MaaT PharmaAugust 31, 2020
New collection campaign to support future clinical development of microbiome biotherapeutic product portfolio and to…
MaaT PharmaAugust 20, 2020
Lyon, France, July 16, 2020 – MaaT Pharma announced today the appointment of Claude Bertrand,…
MaaT PharmaJuly 16, 2020
---MaaT Pharma renforce son équipe de direction en ajoutant une expertise en termes de développement…
MaaT PharmaMay 28, 2020
Lyon, France, May 12, 2020 – MaaT Pharma announced today the appointment of leading international…
nboutaouiMay 12, 2020
In response to the recent “FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation…
MaaT PharmaMarch 13, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
nboutaouiJanuary 31, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
MaaT PharmaJanuary 31, 2020
Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaouiNovember 6, 2019
